Cargando…

Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study

Objectives: Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated diarrhea, often complicated by severe infection and recurrence with increased morbidity and mortality. Data from large cohorts in Switzerland are scarce. We aimed to describe diagnostic assays, treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippidis, Paraskevas, Kampouri, Eleftheria, Woelfle, Maximilian, Badinski, Tina, Croxatto, Antony, Galperine, Tatiana, Papadimitriou-Olivgeris, Matthaios, Grandbastien, Bruno, Achermann, Yvonne, Guery, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267637/
https://www.ncbi.nlm.nih.gov/pubmed/35807087
http://dx.doi.org/10.3390/jcm11133805
_version_ 1784743781215502336
author Filippidis, Paraskevas
Kampouri, Eleftheria
Woelfle, Maximilian
Badinski, Tina
Croxatto, Antony
Galperine, Tatiana
Papadimitriou-Olivgeris, Matthaios
Grandbastien, Bruno
Achermann, Yvonne
Guery, Benoit
author_facet Filippidis, Paraskevas
Kampouri, Eleftheria
Woelfle, Maximilian
Badinski, Tina
Croxatto, Antony
Galperine, Tatiana
Papadimitriou-Olivgeris, Matthaios
Grandbastien, Bruno
Achermann, Yvonne
Guery, Benoit
author_sort Filippidis, Paraskevas
collection PubMed
description Objectives: Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated diarrhea, often complicated by severe infection and recurrence with increased morbidity and mortality. Data from large cohorts in Switzerland are scarce. We aimed to describe diagnostic assays, treatment, outcomes, and risk factors for CDI in a large cohort of patients in Switzerland. Methods: We conducted a retrospective cohort study of CDI episodes diagnosed in patients from two tertiary care hospitals in Switzerland. During a 3-month follow-up, we used a composite outcome combining clinical cure at day 10, recurrence at week 8, or death, to evaluate a patient’s response. Unfavorable outcomes consisted in the occurrence of any of these events. Results: From January 2014 to December 2018, we included 826 hospitalized patients with documented CDI. Overall, 299 patients (36.2%) had a severe infection. Metronidazole was used in 566 patients (83.7%), compared to 82 patients (12.1%) treated with vancomycin and 28 patients (4.1%) treated with fidaxomicin. Overall mortality at week 8 was at 15.3% (112/733). Eighty-six patients (12.7%) presented with clinical failure at day 10, and 78 (14.9%) presented with recurrence within 8 weeks; 269 (39.8%) met the composite outcome of death, clinical failure, or recurrence. The Charlson Comorbidity Index score (p < 0.001), leukocytes > 15 G/L (p = 0.008), and the use of metronidazole (p = 0.012) or vancomycin (p = 0.049) were factors associated with the composite outcome. Conclusions: Our study provides valuable insights on CDI treatment and outcomes in Switzerland, highlights the heterogeneity in practices among centers, and underlines the need for the active monitoring of clinical practices and their impact on clinical outcomes through large multicentric cohorts.
format Online
Article
Text
id pubmed-9267637
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92676372022-07-09 Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study Filippidis, Paraskevas Kampouri, Eleftheria Woelfle, Maximilian Badinski, Tina Croxatto, Antony Galperine, Tatiana Papadimitriou-Olivgeris, Matthaios Grandbastien, Bruno Achermann, Yvonne Guery, Benoit J Clin Med Article Objectives: Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated diarrhea, often complicated by severe infection and recurrence with increased morbidity and mortality. Data from large cohorts in Switzerland are scarce. We aimed to describe diagnostic assays, treatment, outcomes, and risk factors for CDI in a large cohort of patients in Switzerland. Methods: We conducted a retrospective cohort study of CDI episodes diagnosed in patients from two tertiary care hospitals in Switzerland. During a 3-month follow-up, we used a composite outcome combining clinical cure at day 10, recurrence at week 8, or death, to evaluate a patient’s response. Unfavorable outcomes consisted in the occurrence of any of these events. Results: From January 2014 to December 2018, we included 826 hospitalized patients with documented CDI. Overall, 299 patients (36.2%) had a severe infection. Metronidazole was used in 566 patients (83.7%), compared to 82 patients (12.1%) treated with vancomycin and 28 patients (4.1%) treated with fidaxomicin. Overall mortality at week 8 was at 15.3% (112/733). Eighty-six patients (12.7%) presented with clinical failure at day 10, and 78 (14.9%) presented with recurrence within 8 weeks; 269 (39.8%) met the composite outcome of death, clinical failure, or recurrence. The Charlson Comorbidity Index score (p < 0.001), leukocytes > 15 G/L (p = 0.008), and the use of metronidazole (p = 0.012) or vancomycin (p = 0.049) were factors associated with the composite outcome. Conclusions: Our study provides valuable insights on CDI treatment and outcomes in Switzerland, highlights the heterogeneity in practices among centers, and underlines the need for the active monitoring of clinical practices and their impact on clinical outcomes through large multicentric cohorts. MDPI 2022-06-30 /pmc/articles/PMC9267637/ /pubmed/35807087 http://dx.doi.org/10.3390/jcm11133805 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Filippidis, Paraskevas
Kampouri, Eleftheria
Woelfle, Maximilian
Badinski, Tina
Croxatto, Antony
Galperine, Tatiana
Papadimitriou-Olivgeris, Matthaios
Grandbastien, Bruno
Achermann, Yvonne
Guery, Benoit
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study
title Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study
title_full Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study
title_fullStr Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study
title_full_unstemmed Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study
title_short Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study
title_sort treatment and outcomes of clostridioides difficile infection in switzerland: a two-center retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267637/
https://www.ncbi.nlm.nih.gov/pubmed/35807087
http://dx.doi.org/10.3390/jcm11133805
work_keys_str_mv AT filippidisparaskevas treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT kampourieleftheria treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT woelflemaximilian treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT badinskitina treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT croxattoantony treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT galperinetatiana treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT papadimitriouolivgerismatthaios treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT grandbastienbruno treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT achermannyvonne treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy
AT guerybenoit treatmentandoutcomesofclostridioidesdifficileinfectioninswitzerlandatwocenterretrospectivecohortstudy